Merk reported $200M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbott ABT:US $ 123M 12M
Amgen AMGN:US $ 281M 4M
Biogen BIIB:US $ 56.4M 8.3M
Bristol Myers Squibb BMY:US $ 330M 23M
Catalent CTLT:US $ 31.9M 5M
Coherus Biosciences CHRS:US $ 5.75M 0.1M
Drreddys Laboratories RDY:US $ 193M 104M
Eli Lilly And LLY:US $ 86.9M 0.9M
Endo International Ordinary Shares ENDP:US $ 141.64M 6.95M
Gilead Sciences GILD:US $ 256M 1M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Medtronic MDT:US $ 137M 5M
Novartis NOVN:VX 201M 1000K
Novartis NVS:US $ 201M 1M
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Pfizer PFE:US $ 316M 20M
Phibro Animal Health PAHC:US $ 3.03M 0.05M
Prestige Brands PBH:US $ 15.08M 3.91M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Revance Therapeutics RVNC:US $ 1.57M 9K
Teva Pharmaceutical Industries TEVA:US $ 240M 1M
United Therapeutics UTHR:US $ 4.7M 0.1M
Zoetis ZTS:US $ 57M 0M